Additionally, the authors performed an ELISA-based validation study to measure serum IL-8 levels in Prostate Cancer (PCa) patients grouped by genotype.<h4>Results</h4>The +2767 polymorphism was associated with a significant reduction in overall cancer risk. Here, CXCL8 is linked to prostate cancer.